Psychiatric News (11/1) reports, “Women who begin taking oral or transdermal estrogen or estrogen/progestin for menopause between the ages of 45 and 50 appear to be at greater risk of developing depression,” investigators concluded in a study that “included 825,238 women in Denmark who turned 45 years between 1995 and the end of 2017.” The findings were published online Nov. 1 in JAMA Network Open.
Related Links:
— “Oral, Transdermal Hormone Therapy for Menopause Before Age 50 May Increase Risk of Depression, Psychiatric News , November 1, 2022